JAMA Clinical Reviews Superficial Vein Thrombosis
78 snips
Sep 15, 2025 In this discussion, Behnood Bikdeli, a cardiologist at Brigham and Women’s Hospital, delves into the complexities of superficial vein thrombosis (SuVT). He outlines the pathophysiology, risk factors, and crucial symptoms associated with the condition. Bikdeli emphasizes the significance of Doppler ultrasound in diagnosis and the potential transition to deep vein thrombosis. Treatment strategies, including the use of warm compresses and the selective application of anticoagulation, are also thoroughly explored, highlighting tailored approaches for high-risk patients.
AI Snips
Chapters
Transcript
Episode notes
Saphenous Veins Are Primary SuVT Sites
- In the lower limb SuVT, the great saphenous vein is by far the most commonly involved site.
- The great saphenous accounts for >70% of lower-extremity cases and the small saphenous for ~20–25%.
Prevent Propagation At Venous Junctions
- Treat SuVT partly to prevent propagation into deep veins, especially near venous junctions.
- Recognize saphenofemoral junction proximity as a key factor because propagation increases risk of pulmonary embolism.
Use Distance And Length To Guide Anticoagulation
- If SuVT is within 3 cm of a deep venous junction, treat with therapeutic-intensity anticoagulation.
- For thrombi ≥5 cm but farther from junctions, use lower-intensity anticoagulation (e.g., fondaparinux or rivaroxaban) or consider observation if smaller and remote.